AR026655A1 - Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica - Google Patents

Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica

Info

Publication number
AR026655A1
AR026655A1 ARP000106304A ARP000106304A AR026655A1 AR 026655 A1 AR026655 A1 AR 026655A1 AR P000106304 A ARP000106304 A AR P000106304A AR P000106304 A ARP000106304 A AR P000106304A AR 026655 A1 AR026655 A1 AR 026655A1
Authority
AR
Argentina
Prior art keywords
androgenic
insufficiency
male
antinconceptives
steroids
Prior art date
Application number
ARP000106304A
Other languages
English (en)
Spanish (es)
Original Assignee
Adam Worrall Julia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adam Worrall Julia filed Critical Adam Worrall Julia
Publication of AR026655A1 publication Critical patent/AR026655A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP000106304A 1999-12-02 2000-11-30 Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica AR026655A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02

Publications (1)

Publication Number Publication Date
AR026655A1 true AR026655A1 (es) 2003-02-19

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106304A AR026655A1 (es) 1999-12-02 2000-11-30 Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC10.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003515543A (cg-RX-API-DMAC10.html)
CN (1) CN1166680C (cg-RX-API-DMAC10.html)
AR (1) AR026655A1 (cg-RX-API-DMAC10.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC10.html)
AU (1) AU778017B2 (cg-RX-API-DMAC10.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC10.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC10.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC10.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC10.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC10.html)
HK (1) HK1047596B (cg-RX-API-DMAC10.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC10.html)
IL (1) IL149424A (cg-RX-API-DMAC10.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC10.html)
NO (1) NO322422B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ518753A (cg-RX-API-DMAC10.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC10.html)
PL (1) PL202999B1 (cg-RX-API-DMAC10.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC10.html)
SK (1) SK287095B6 (cg-RX-API-DMAC10.html)
TW (1) TWI275593B (cg-RX-API-DMAC10.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1470151B1 (en) * 2002-01-21 2009-12-30 N.V. Organon Process for the preparation of 7-alpha-methylsteroids
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
AU2012320423C1 (en) * 2011-10-07 2018-01-25 Estetra Srl Process for the production of estetrol
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
EP3701944B1 (en) 2015-06-18 2021-12-08 Estetra SRL Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) 2018-04-19 2022-02-09 Estetra SRL Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Also Published As

Publication number Publication date
NO20022564D0 (no) 2002-05-30
NO322422B1 (no) 2006-10-02
IL149424A (en) 2007-05-15
ZA200203536B (en) 2003-08-04
CN1402735A (zh) 2003-03-12
US6706700B2 (en) 2004-03-16
PL355689A1 (en) 2004-05-17
CZ20021894A3 (cs) 2002-08-14
CA2390226A1 (en) 2001-06-07
DE60025958D1 (de) 2006-04-20
HK1047596B (en) 2006-04-21
AU2838301A (en) 2001-06-12
CZ301376B6 (cs) 2010-02-03
PL202999B1 (pl) 2009-08-31
SK287095B6 (sk) 2009-12-07
NZ518753A (en) 2004-05-28
HK1047596A1 (en) 2003-02-28
SK7582002A3 (en) 2002-09-10
DE60025958T2 (de) 2006-07-27
RU2242479C2 (ru) 2004-12-20
HUP0203611A2 (hu) 2003-03-28
US20030100543A1 (en) 2003-05-29
WO2001040255A2 (en) 2001-06-07
WO2001040255A3 (en) 2001-11-15
JP2003515543A (ja) 2003-05-07
NO20022564L (no) 2002-05-30
MXPA02004939A (es) 2003-05-23
ATE317396T1 (de) 2006-02-15
CY1106086T1 (el) 2011-06-08
CN1166680C (zh) 2004-09-15
EP1237904B1 (en) 2006-02-08
DK1237904T3 (da) 2006-06-06
PE20011033A1 (es) 2001-10-11
CO5251441A1 (es) 2003-02-28
HUP0203611A3 (en) 2004-07-28
TWI275593B (en) 2007-03-11
AU778017B2 (en) 2004-11-11
ES2258037T3 (es) 2006-08-16
IL149424A0 (en) 2002-11-10
EP1237904A2 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
PT748190E (pt) Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos
ES2190469T3 (es) Derivados de isocumarina y su uso en farmacos.
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
ECSP083351A (es) Composiciones farmacéuticas
AR027059A1 (es) Bases de mannich indolicas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para la preparacion de medicamentos
ATE212351T1 (de) Androsten-derivate
PT1235571E (pt) Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
SE9900961D0 (sv) Novel compounds
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
SE9701161D0 (sv) New use I
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DE60021720D1 (de) Androgen glykoside und die androgenische aktivität davon
CY1106086T1 (el) Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR022852A1 (es) Nuevos androgenos
AR005704A1 (es) Heteroariloxazolidinonas
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
AR009322A1 (es) Nuevas aril-piridazinas

Legal Events

Date Code Title Description
FG Grant, registration